165 related articles for article (PubMed ID: 23507476)
1. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501.
Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M
J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476
[TBL] [Abstract][Full Text] [Related]
2. ALCAM and CD6--multiple sclerosis risk factors.
Wagner M; Bilinska M; Pokryszko-Dragan A; Sobczynski M; Cyrul M; Kusnierczyk P; Jasek M
J Neuroimmunol; 2014 Nov; 276(1-2):98-103. PubMed ID: 25216742
[TBL] [Abstract][Full Text] [Related]
3. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran.
Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A
J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442
[TBL] [Abstract][Full Text] [Related]
4. Contributions of vitamin D response elements and HLA promoters to multiple sclerosis risk.
Nolan D; Castley A; Tschochner M; James I; Qiu W; Sayer D; Christiansen FT; Witt C; Mastaglia F; Carroll W; Kermode A
Neurology; 2012 Aug; 79(6):538-46. PubMed ID: 22786591
[TBL] [Abstract][Full Text] [Related]
5. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis.
Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A
Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892
[TBL] [Abstract][Full Text] [Related]
6. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
[TBL] [Abstract][Full Text] [Related]
7. Genome wide differences of gene expression associated with HLA-DRB1 genotype in multiple sclerosis: a pilot study.
Apperson ML; Tian Y; Stamova B; Ander BP; Jickling GC; Agius MA; Sharp FR
J Neuroimmunol; 2013 Apr; 257(1-2):90-6. PubMed ID: 23477965
[TBL] [Abstract][Full Text] [Related]
8. The relationship between HLA-DRB1 alleles and optic neuritis in Irish patients and the risk of developing multiple sclerosis.
Tuwir I; Dunne C; Crowley J; Saddik T; Murphy R; Cassidy L
Br J Ophthalmol; 2007 Oct; 91(10):1288-92. PubMed ID: 17895416
[TBL] [Abstract][Full Text] [Related]
9. Combination of Myelin Basic Protein Gene Polymorphisms with HLA-DRB1*1501 in Iranian Patients with Multiple Sclerosis.
Nejati P; Attar M; Rahimian M; Fathi D; Shahbazi M
Iran J Immunol; 2017 Sep; 14(3):231-239. PubMed ID: 28919586
[TBL] [Abstract][Full Text] [Related]
10. HLA associations with multiple sclerosis in Greece.
Kouri I; Papakonstantinou S; Bempes V; Vasiliadis HS; Kyritsis AP; Pelidou SH
J Neurol Sci; 2011 Sep; 308(1-2):28-31. PubMed ID: 21741664
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1*15:01 and multiple sclerosis: a female association?
Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D
Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897
[TBL] [Abstract][Full Text] [Related]
12. Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Lindén M; Khademi M; Lima Bomfim I; Piehl F; Jagodic M; Kockum I; Olsson T
Mult Scler; 2013 Jun; 19(7):863-70. PubMed ID: 23175382
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis risk markers in HLA-DRA, HLA-C, and IFNG genes are associated with sex-specific childhood leukemia risk.
Morrison BA; Ucisik-Akkaya E; Flores H; Alaez C; Gorodezky C; Dorak MT
Autoimmunity; 2010 Dec; 43(8):690-7. PubMed ID: 21067287
[TBL] [Abstract][Full Text] [Related]
14. HLA (A-B-C and -DRB1) alleles and brain MRI changes in multiple sclerosis: a longitudinal study.
Liguori M; Healy BC; Glanz BI; Khoury SJ; Moscufo N; Weiner HL; De Jager PL; Guttmann CR
Genes Immun; 2011 Apr; 12(3):183-90. PubMed ID: 21179117
[TBL] [Abstract][Full Text] [Related]
15. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients.
Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M
Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147
[TBL] [Abstract][Full Text] [Related]
16. Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis.
Cox MB; Ban M; Bowden NA; Baker A; Scott RJ; Lechner-Scott J
Mult Scler; 2012 Jan; 18(1):16-22. PubMed ID: 21816760
[TBL] [Abstract][Full Text] [Related]
17. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese.
Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J;
Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis.
Barcellos LF; Sawcer S; Ramsay PP; Baranzini SE; Thomson G; Briggs F; Cree BC; Begovich AB; Villoslada P; Montalban X; Uccelli A; Savettieri G; Lincoln RR; DeLoa C; Haines JL; Pericak-Vance MA; Compston A; Hauser SL; Oksenberg JR
Hum Mol Genet; 2006 Sep; 15(18):2813-24. PubMed ID: 16905561
[TBL] [Abstract][Full Text] [Related]
19. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis.
Stankovich J; Butzkueven H; Marriott M; Chapman C; Tubridy N; Tait BD; Varney MD; Taylor BV; Foote SJ; ; Kilpatrick TJ; Rubio JP
Tissue Antigens; 2009 Jul; 74(1):17-21. PubMed ID: 19392788
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in ALCAM and other chromosomal instability genes in breast cancer survival.
Varadi V; Bevier M; Grzybowska E; Johansson R; Enquist-Olsson K; Henriksson R; Butkiewicz D; Pamula-Pilat J; Tecza K; Hemminki K; Lenner P; Försti A
Breast Cancer Res Treat; 2012 Jan; 131(1):311-9. PubMed ID: 21935604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]